Xconomy’s Digital Events →
December 3, 2020 · New York
Adimab is developing a yeast-based technology for discovering therapeutic antibodies.
Sponsored · Whitepaper
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
Decentralized Trials: Reshaping the Rare Disease Landscape
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.